|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | |||||||
| Accounts receivable, net | |||||||
| Nonrelated Party | |||||||
| Related Party | |||||||
| Total accounts receivable, net | |||||||
| Inventories, net | |||||||
| Due from related party | |||||||
| Related Party | |||||||
| Total due from related party | |||||||
| Subscription receivable | |||||||
| Deferred offering costs | |||||||
| Prepaid and other current assets | |||||||
| Total current assets | |||||||
| Property, plant and equipment, net | |||||||
| Intangible assets under development | |||||||
| Capitalized software | |||||||
| Operating lease, right-of-use assets | |||||||
| Goodwill | |||||||
| Other intangible assets, net | |||||||
| Note receivable | |||||||
| Investments in unconsolidated entity | |||||||
| Other assets | |||||||
| Deposits | |||||||
| Total assets | |||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||
| Current liabilities: | |||||||
| Accounts payable | |||||||
| Nonrelated Party | |||||||
| Related Party | |||||||
| Accrued expenses and other liabilities | |||||||
| Other short-term advances | |||||||
| Due to related parties | |||||||
| Nonrelated Party | |||||||
| Seller | |||||||
| Related Party | |||||||
| Total due to related parties | |||||||
| Convertible notes payable, net of debt discount | |||||||
| Current portion of debt obligations, net of debt discount | |||||||
| Operating lease liabilities- current portion | |||||||
| Total current liabilities | |||||||
| Notes payable | |||||||
| Nonrelated Party | |||||||
| Related Party | |||||||
| Loan payable | |||||||
| Operating lease liabilities | |||||||
| Total liabilities | |||||||
| Stockholders’ equity (deficit): | |||||||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 2,847,198 and 2,045,792 shares issued and 2,836,484 and 2,026,150 shares outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total stockholders’ equity (deficit) | |||||||
| Total liabilities and stockholders’ equity (deficit) |
Loading...